# Induced Sputum Study (0000-065)

> **NCT00623714** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 13 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Comparator: fluticasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00623714
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623714, "Induced Sputum Study (0000-065)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00623714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*